381 related articles for article (PubMed ID: 21491437)
1. The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.
Houde D; Berkowitz SA; Engen JR
J Pharm Sci; 2011 Jun; 100(6):2071-86. PubMed ID: 21491437
[TBL] [Abstract][Full Text] [Related]
2. H/D exchange centroid monitoring is insufficient to show differences in the behavior of protein states.
Zhang J; Ramachandran P; Kumar R; Gross ML
J Am Soc Mass Spectrom; 2013 Mar; 24(3):450-3. PubMed ID: 23397137
[TBL] [Abstract][Full Text] [Related]
3. Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.
Kaltashov IA; Bobst CE; Abzalimov RR; Berkowitz SA; Houde D
J Am Soc Mass Spectrom; 2010 Mar; 21(3):323-37. PubMed ID: 19963397
[TBL] [Abstract][Full Text] [Related]
4. Multidimensional methods for the formulation of biopharmaceuticals and vaccines.
Maddux NR; Joshi SB; Volkin DB; Ralston JP; Middaugh CR
J Pharm Sci; 2011 Oct; 100(10):4171-97. PubMed ID: 21647886
[TBL] [Abstract][Full Text] [Related]
5. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.
Kaltashov IA; Bobst CE; Abzalimov RR; Wang G; Baykal B; Wang S
Biotechnol Adv; 2012; 30(1):210-22. PubMed ID: 21619926
[TBL] [Abstract][Full Text] [Related]
6. Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.
Bobst CE; Kaltashov IA
Curr Pharm Biotechnol; 2011 Oct; 12(10):1517-29. PubMed ID: 21542797
[TBL] [Abstract][Full Text] [Related]
7. An Industry Perspective on the use of Forced Degradation Studies to Assess Comparability of Biopharmaceuticals.
Campbell JM; Colombo S; Doyle JL; Filoti DI; Hübner G; Magnenat L; Nowinski AK; Pavon JA; Singh SM; Vo LR; Woods JM; Stokes ESE
J Pharm Sci; 2024 Mar; 113(3):505-512. PubMed ID: 38103689
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive assessment of the applicability of RoboColumn as a chromatography scale-down model for use in biopharmaceutical process validation.
Chinn M; Doninger K; Al-Khaledy R; Zhang E; Kim H; Werz S; Schelter F
J Chromatogr A; 2023 Nov; 1710():464391. PubMed ID: 37769427
[TBL] [Abstract][Full Text] [Related]
9. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review.
Deng B; Lento C; Wilson DJ
Anal Chim Acta; 2016 Oct; 940():8-20. PubMed ID: 27662755
[TBL] [Abstract][Full Text] [Related]
11. An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery.
Masson GR; Jenkins ML; Burke JE
Expert Opin Drug Discov; 2017 Oct; 12(10):981-994. PubMed ID: 28770632
[TBL] [Abstract][Full Text] [Related]
12. Analytical Aspects of Hydrogen Exchange Mass Spectrometry.
Engen JR; Wales TE
Annu Rev Anal Chem (Palo Alto Calif); 2015; 8():127-48. PubMed ID: 26048552
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies.
Majumdar R; Middaugh CR; Weis DD; Volkin DB
J Pharm Sci; 2015 Feb; 104(2):327-45. PubMed ID: 25354868
[TBL] [Abstract][Full Text] [Related]
14. Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.
Iacob RE; Bou-Assaf GM; Makowski L; Engen JR; Berkowitz SA; Houde D
J Pharm Sci; 2013 Dec; 102(12):4315-29. PubMed ID: 24136070
[TBL] [Abstract][Full Text] [Related]
15. Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars.
Berkowitz SA; Engen JR; Mazzeo JR; Jones GB
Nat Rev Drug Discov; 2012 Jun; 11(7):527-40. PubMed ID: 22743980
[TBL] [Abstract][Full Text] [Related]
16. Effects of sucrose and benzyl alcohol on GCSF conformational dynamics revealed by hydrogen deuterium exchange mass spectrometry.
Zhang J; Banks DD; He F; Treuheit MJ; Becker GW
J Pharm Sci; 2015 May; 104(5):1592-600. PubMed ID: 25693946
[TBL] [Abstract][Full Text] [Related]
17. Reliable Identification of Significant Differences in Differential Hydrogen Exchange-Mass Spectrometry Measurements Using a Hybrid Significance Testing Approach.
Hageman TS; Weis DD
Anal Chem; 2019 Jul; 91(13):8008-8016. PubMed ID: 31099554
[TBL] [Abstract][Full Text] [Related]
18. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry.
Baggen J; Jacquemyn M; Persoons L; Vanstreels E; Pye VE; Wrobel AG; Calvaresi V; Martin SR; Roustan C; Cronin NB; Reading E; Thibaut HJ; Vercruysse T; Maes P; De Smet F; Yee A; Nivitchanyong T; Roell M; Franco-Hernandez N; Rhinn H; Mamchak AA; Ah Young-Chapon M; Brown E; Cherepanov P; Daelemans D
Cell; 2023 Aug; 186(16):3427-3442.e22. PubMed ID: 37421949
[TBL] [Abstract][Full Text] [Related]
19. Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein.
Calvaresi V; Wrobel AG; Toporowska J; Hammerschmid D; Doores KJ; Bradshaw RT; Parsons RB; Benton DJ; Roustan C; Reading E; Malim MH; Gamblin SJ; Politis A
Nat Commun; 2023 Mar; 14(1):1421. PubMed ID: 36918534
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
Niemeyer D; Stenzel S; Veith T; Schroeder S; Friedmann K; Weege F; Trimpert J; Heinze J; Richter A; Jansen J; Emanuel J; Kazmierski J; Pott F; Jeworowski LM; Olmer R; Jaboreck MC; Tenner B; Papies J; Walper F; Schmidt ML; Heinemann N; Möncke-Buchner E; Baumgardt M; Hoffmann K; Widera M; Thao TTN; Balázs A; Schulze J; Mache C; Jones TC; Morkel M; Ciesek S; Hanitsch LG; Mall MA; Hocke AC; Thiel V; Osterrieder K; Wolff T; Martin U; Corman VM; Müller MA; Goffinet C; Drosten C
PLoS Biol; 2022 Nov; 20(11):e3001871. PubMed ID: 36383605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
